SCHEMBL7746499

SCHEMBL7746499

Cc1nn(Cc2nc3ccccc3n2CCCCF)c2ccccc2c1=O

nearest known ligand 0.42

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
USP2 O75604 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
RECQL P46063 1/20 0.42
GAA P10253 2/20 0.41
TP53 P04637 2/20 0.41
MAPT P10636 2/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
POLB P06746 2/20 0.40
HPGD P15428 1/20 0.40
TSHR P16473 1/20 0.40
AKR1B1 P15121 1/20 0.40
RAB9A P51151 1/20 0.39
TOP2A P11388 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6241459 0.88 MEN1 (0.41) MEN1KMT2ARECQLHPGD
SCHEMBL7746317 0.74 MEN1 (0.43) MEN1KMT2AUSP2L3MBTL1RECQL
SCHEMBL6480122 0.74 TSHR (0.41) MEN1KMT2AUSP2L3MBTL1RECQL
SCHEMBL7745480 0.74 TOP2A (0.47) MEN1KMT2AUSP2L3MBTL1RECQL
SCHEMBL7741901 0.74 POLB (0.44) MEN1KMT2AUSP2L3MBTL1RECQL
SCHEMBL7741401 0.72 MEN1 (0.59) MEN1KMT2AUSP2L3MBTL1RECQL
SCHEMBL7746045 0.72 SMN1; SMN2 (0.64) MEN1KMT2ATP53SMN1; SMN2POLB
SCHEMBL7746911 0.72 MEN1 (0.45) MEN1KMT2AUSP2L3MBTL1RECQL
SCHEMBL7740409 0.72 MEN1 (0.42) MEN1KMT2AUSP2L3MBTL1RECQL
SCHEMBL7745852 0.72 CYP3A4 (0.59) MEN1KMT2AUSP2L3MBTL1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6774134-B2 FOR THERAPY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION BRISTOL-MYERS SQUIBB COMPANY 2004-08-10 US disclosed
US-6774134-B2 FOR THERAPY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION BRISTOL-MYERS SQUIBB COMPANY 2004-08-10 US disclosed